Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Buildings: 2009-2010

  • Cumberland Pharmaceuticals' Buildings rose 53.28% to $931.1 billion in Q4 2010 from the same period last year, while for Dec 2010 it was $931.1 billion, marking a year-over-year increase of 53.28%. This contributed to the annual value of $931.1 billion for FY2010, which is 53.28% up from last year.
  • Per Cumberland Pharmaceuticals' latest filing, its Buildings stood at $931.1 billion for Q4 2010, which was up 53.28% from $607.4 billion recorded in Q4 2009.
  • Over the past 5 years, Cumberland Pharmaceuticals' Buildings peaked at $931.1 billion during Q4 2010, and registered a low of $607.4 billion during Q4 2009.
  • In the last 2 years, Cumberland Pharmaceuticals' Buildings had a median value of $769.3 billion in 2009 and averaged $769.3 billion.
  • Data for Cumberland Pharmaceuticals' Buildings shows a peak YoY skyrocketed of 53.28% (in 2010) over the last 5 years.
  • Quarterly analysis of 2 years shows Cumberland Pharmaceuticals' Buildings stood at $607.4 billion in 2009, then skyrocketed by 53.28% to $931.1 billion in 2010.